Class of chemical compounds
Lysergamides, also known as ergoamides or as lysergic acid amides, are amides of lysergic acid (LA). They are ergolines, with some lysergamides being found naturally in ergot as well as other fungi. Lysergamides are notable in containing embedded phenethylamine and tryptamine moieties within their ergoline ring system.
The simplest lysergamides are ergine (lysergic acid amide; LSA) and isoergine (iso-lysergic acid amide; iso-LSA). In terms of pharmacology, the lysergamides include numerous serotonin and dopamine receptor agonists, most notably the psychedelic drug lysergic acid diethylamide (LSD) but also a number of pharmaceutical drugs like ergometrine, methylergometrine, methysergide, and cabergoline. Various analogues of LSD, such as the psychedelics ALD-52 (1A-LSD), ETH-LAD, LSZ, and 1P-LSD and the non-hallucinogenic 2-bromo-LSD (BOL-148), have also been developed. Ergopeptines like ergotamine, dihydroergotamine, and bromocriptine are also lysergamides, but with addition of a small peptide moiety at the amide. Close analogues of lysergamides that are not technically lysergamides themselves include lisuride, terguride, bromerguride, and JRT.
Lysergamides were first discovered and described in the 1930s.
Simplified or partial ergolines and lysergamides, such as NDTDI (8,10-seco-LSD), DEMPDHPCA, and N-DEAOP-NMT, are also known.
Safety at a Glance
High Risk- General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual se...
- Toxicity: The toxicity profile of Lysergamides, like most classical psychedelics, suggests a relatively favorable physiological...
- Overdose risk: Fatal overdose from Lysergamides alone, at doses within the typical recreational range, is extrem...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Duration
No duration data available.
How It Feels
The lysergamide class encompasses compounds derived from or structurally related to lysergic acid, including LSD and its many analogues and prodrugs. As a class, they produce what many consider the archetypal psychedelic experience: a seamless fusion of visual, cognitive, and emotional alteration that unfolds over a moderate to long duration.
The lysergamide signature includes vivid visual enhancement featuring flowing geometric patterns, kaleidoscopic symmetry, and a characteristic prismatic quality to light. Colors become richly saturated without the neon harshness of some phenethylamines. The cognitive space is expansive and deeply introspective, with a tendency toward recursive thought loops, creative insight, and examination of fundamental assumptions. The emotional landscape is vast and responsive to set and setting.
Physically, lysergamides produce mild to moderate stimulation, pupil dilation, and a characteristic jaw tension. The body load is generally manageable, and the safety profile is among the best of any psychedelic class. Duration typically ranges from six to twelve hours, with a long, gradual afterglow. The class is notable for the number of structural variations available, each offering subtle differences in visual character, headspace depth, body load, and duration while maintaining the essential lysergamide quality.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(8)
- Body load— A diffuse, heavy physical discomfort involving tension, pressure, and malaise in the torso and limbs...
- Muscle tension— Persistent partial contractions or tightening of muscles that produces uncomfortable stiffness, cram...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
- Serotonin syndrome— Serotonin syndrome is a potentially fatal medical emergency caused by excessive serotonergic activit...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Cognitive & Perceptual Effects
Visual(5)
- Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Symmetrical texture repetition— Textures appear to mirror and tessellate across surfaces in intricate, self-similar symmetrical patt...
- Tracers— Moving objects leave visible trails of varying length and opacity behind them, similar to long-expos...
- Transformations— Objects and scenery undergo perceived visual metamorphosis, smoothly shapeshifting into other recogn...
Cognitive(7)
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
- Introspection— An enhanced state of self-reflective awareness in which one feels drawn to examine their own thought...
- Novelty enhancement— A feeling of increased fascination, awe, and childlike wonder attributed to everyday concepts, objec...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
- Thought loops— Becoming trapped in a repeating cycle of thoughts, actions, and emotions that loops every few second...
Transpersonal(1)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
Pharmacology
Lysergamides exerts its primary psychoactive effects through agonism or partial agonism at serotonin 5-HT2A receptors in the cortex, particularly in layer V pyramidal neurons. This receptor activation triggers a cascade of downstream signaling involving increased glutamate release in the prefrontal cortex and altered thalamocortical communication, which is thought to underlie the characteristic perceptual and cognitive effects.
Secondary pharmacological actions may include affinity for other serotonin receptor subtypes (5-HT2C, 5-HT1A), as well as trace amine-associated receptors (TAARs). The relative binding affinities at these various targets contribute to the unique subjective profile of Lysergamides compared to other psychedelics.
The duration and intensity of effects are influenced by the compound's pharmacokinetic properties, including absorption rate, blood-brain barrier permeability, metabolism (primarily hepatic, involving CYP450 enzymes), and receptor binding kinetics. Functional selectivity at the 5-HT2A receptor — meaning the specific intracellular signaling pathways activated — may also play a role in differentiating the subjective character of different psychedelic compounds.
Interactions
No documented interactions.
History
The history of Lysergamides is intertwined with the broader story of psychedelic research, which has oscillated between periods of intense scientific interest and strict prohibition.
Like many psychedelic compounds, Lysergamides was either synthesized in a laboratory setting or identified as a naturally occurring psychoactive substance through ethnobotanical research. The mid-20th century saw an explosion of interest in psychedelic compounds, with researchers exploring their potential applications in psychotherapy, creativity enhancement, and the study of consciousness.
The political and cultural backlash of the late 1960s and early 1970s led to the criminalization of most psychedelic substances, effectively halting legitimate research for decades. The resurgence of psychedelic research beginning in the 2000s — often called the "psychedelic renaissance" — has renewed scientific interest in this class of compounds, with clinical trials exploring applications in treatment-resistant depression, PTSD, end-of-life anxiety, and addiction.
Lysergamides exists within this broader pharmacological and cultural context, with its specific history shaped by its date of discovery, legal status, availability, and unique pharmacological profile.
Harm Reduction
General Principles
- Start low, go slow: Always begin with a low dose, especially with unfamiliar batches or new substances. Individual sensitivity varies enormously.
- Test your substances: Use reagent test kits to verify identity and check for dangerous adulterants. Consider using drug checking services where available.
- Research thoroughly: Understand expected dose ranges, duration, potential interactions, and contraindications before use.
- Never use alone: Have a trusted, sober person present, especially with new substances or higher doses.
- Set and setting: Your mindset and environment profoundly influence the experience. Choose a safe, comfortable environment and ensure you're in a stable psychological state.
Lysergamides-Specific Harm Reduction
- Integration: Allow time between experiences to integrate insights. Using psychedelics too frequently can lead to psychological distress.
- Trip sitter: A sober, experienced sitter is invaluable, especially at higher doses. They should be briefed on what to expect and how to help.
- Difficult experiences: If anxiety occurs, change the setting (different room, different music), practice slow breathing, and remember the effects are temporary. Having a benzodiazepine available (not for routine use) can provide reassurance.
- Duration planning: Ensure you have no obligations for the full duration plus several hours of recovery time.
- Contraindications: Avoid combining with lithium (seizure risk), tramadol (seizure risk), or SSRIs (reduced effects, potential serotonin issues). Those with personal or family history of psychotic disorders should exercise extreme caution.
Toxicity & Safety
The toxicity profile of Lysergamides, like most classical psychedelics, suggests a relatively favorable physiological safety margin. Classical psychedelics as a class have among the lowest organ toxicity of any psychoactive substances, with therapeutic indices far exceeding those of many common medications.
Physical toxicity: The primary physical risks associated with Lysergamides are indirect — injuries resulting from impaired judgment during the acute experience. Direct organ toxicity at typical recreational doses has not been well-established. However, the long-term effects of repeated use are not fully characterized.
Psychological risks: The more significant risks are psychological. These include acute anxiety/panic reactions ("bad trips"), triggering or exacerbating latent psychiatric conditions (particularly psychotic disorders), and Hallucinogen Persisting Perception Disorder (HPPD) — a condition involving persistent visual disturbances after use.
Serotonin syndrome: Combining Lysergamides with serotonergic medications (MAOIs, SSRIs) can elevate serotonin to dangerous levels. This interaction requires particular caution.
Dependence potential: Lysergamides is not considered physically addictive, and tolerance to psychedelic effects develops rapidly (within days), making daily use impractical. Psychological dependence, while possible, is relatively uncommon compared to other substance classes.
It is strongly recommended that one use harm reduction practices when using this substance.
Overdose Information
Fatal overdose from Lysergamides alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.
However, psychological emergencies can occur and require appropriate response:
- Severe anxiety, panic, or psychotic episodes
- Dangerous behavior due to impaired reality testing
- Self-harm in the context of a distressing experience
Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.
Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.
Tolerance
| Full | Unknown |
| Half | Unknown |
| Zero | Unknown |
Legal Status
The legal status of Lysergamides varies by jurisdiction and is subject to change. This information is provided for educational purposes and may not reflect the most current legislation.
General patterns: Many psychoactive substances are controlled under national and international drug control frameworks, including the United Nations Single Convention on Narcotic Drugs (1961), the Convention on Psychotropic Substances (1971), and country-specific legislation such as the US Controlled Substances Act, UK Misuse of Drugs Act, and EU Framework Decisions.
Research chemicals and analogues: Novel psychoactive substances may be captured by analogue laws (e.g., the US Federal Analogue Act) or blanket bans on substance classes (e.g., the UK Psychoactive Substances Act 2016), even if the specific compound is not individually scheduled.
Important note: Possessing, distributing, or manufacturing controlled substances carries serious legal consequences in most jurisdictions. Legal status is not a reliable indicator of a substance's safety profile — some highly dangerous substances are legal, while some with favorable safety profiles are strictly controlled.
Users are strongly encouraged to research the specific legal status of Lysergamides in their jurisdiction before any involvement with this substance.
Experience Reports (2)
Tips (5)
Keep a usage log for Lysergamides including dose, time, effects, and side effects. This helps you identify patterns and prevent problematic escalation.
Research potential interactions before combining Lysergamides with other substances. Drug interactions can be unpredictable and dangerous.
Store lysergamides in amber glass vials in a cool, dark, dry place. These compounds are sensitive to light, heat, and moisture. Properly stored, they can maintain potency for years. Wrapping blotters in aluminum foil and placing them in an airtight container in the freezer is the gold standard for long-term storage.
Among the lysergamide class, potency and character vary significantly. LSD remains the gold standard, but research lysergamides like 1P-LSD, ALD-52, and ETH-LAD each have subtle differences in headspace, visual character, and duration. ETH-LAD in particular is known for being more visual but also more likely to cause nausea and body load at higher doses.
When trying a new lysergamide for the first time, always start with a threshold dose even if you're experienced with LSD. Potency curves and dose-response relationships differ between analogs. What's a moderate dose of one lysergamide could be overwhelming for another. ETH-LAD in particular has a steeper dose-response curve than LSD.
Community Discussions (4)
See Also
References (2)
- Lysergamides - TripSit Factsheet
TripSit factsheet for Lysergamides
tripsit - Lysergamides - Wikipedia
Wikipedia article on Lysergamides
wikipedia